DOXYLAMINE KRKA 15 mg, film-coated tablet scored 10 tablets
Active ingredients: Doxylamine succinate
Commercialized according to BDPM
Film-coated tablet scored10 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DOXYLAMINE KRKA 15 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 10 comprimé(s)
- Marketing authorisation holder
- KRKA (SLOVENIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Sept 2019
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67698929CIP73015880CIP133400930158807Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROGÉNOSUCCINATE DE DOXYLAMINEcomprimé | 15,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.